Delivery Order 75F40118D10023-75F40118F01001
Award Date 9/21/18
Potential Completion Date 9/23/19
Potential Value $6M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Time and Materials
Place of Performance
Fairfax, VA 22031, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $4,415,338.31 delivery order contract awarded by the Center for Biologics Evaluation and Research (CBER) of the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc., a prominent for-profit healthcare data and analytics provider. The contract is for the CBER's Biologics Effectiveness and Safety (BEST) Initiative #3, which focuses on utilizing healthcare data sources for surveillance of biologics (BEST 3). The contract is a time and materials type with a period of...
- The Department of Health and Human Services Food and Drug Administration awarded a $5,273,171.50 delivery order contract to Iqvia Government Solutions Inc. to conduct surveillance activities for the safety and effectiveness of biologics. This contract is part of the BEST Initiative, a larger indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle for data tools and infrastructure to support surveillance of biologics. Iqvia Government Solutions is a for-profit organization that has...
- The Food and Drug Administration (FDA), through its Center for Biologics Evaluation and Research (CBER), awarded a $6.16 million delivery order on September 27, 2024, to Iqvia Government Solutions Inc. under the Biologics Effectiveness and Safety (BEST) Initiative #3, focused on Health Care Data Sources for Surveillance of Biologics. This contract, which operates on a time and materials pricing model with an ultimate completion date of October 30, 2025, will be performed in Falls Church,...
- The Department of Health and Human Services Food and Drug Administration awarded a $2.68 million delivery order against the BEST Initative - Data Sources For Surveillance of Biologics master IDIQ to Iqvia Government Solutions Inc. The one-year order, with a period of performance from September 2020 through September 2021, will provide products and services in support of the BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS effort. Under a time...
- This is a $2,442,983.29 time-and-materials contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Iqvia Government Solutions Inc., a for-profit provider of healthcare data, analytics, and related services to federal agencies. The contract is for the Biologics Effectiveness and Safety (BEST) Initiative, which involves blood and blood products safety surveillance. No set-aside was used. Iqvia has held several past and current IDIQ contracts with the...
- This is a delivery order awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) to develop and enhance the current Center for Biologics Evaluation and Research (CBER) capabilities with respect to electronic health data sources, infrastructure, methods, and tools. The purpose is to conduct surveillance and epidemiologic studies to assure the safety and effectiveness of biologic products including...
- This is a delivery order awarded to Iqvia Government Solutions Inc. under the Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics indefinite delivery, indefinite quantity (IDIQ) contract with the Food and Drug Administration (FDA). The $17,498,031.84 award will provide data sources to conduct surveillance of biologics, covering tens of millions of patients from insurers, payers, and providers. The BEST Initiative IDIQ is valued at $50 million and...
- The U.S. Department of Health and Human Services Food and Drug Administration awarded a $14,609,200.89 delivery order contract to International Business Machines Corporation (IBM) for the "DEVELOPMENT OF NEW AND INNOVATIVE METHODS FOR AUTOMATED REPORTING FOR CBER-REGULATED BIOLOGICAL PRODUCTS". This contract is a Time and Materials type under the BEST Initiative - New and Innovative Methods for Automated Reporting master IDIQ. The contract does not have a set-aside designation. IBM, as...
- This federal contract award was issued by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) to support the Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative. The $8,234,421.12 delivery order contract will develop new and innovative methods for automated reporting for CBER-regulated biologics. The contract is a Time and Materials (T&M) type and does not have a set-aside designation. IBM will be...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $13.2 million delivery order contract to International Business Machines Corporation (IBM) under the Biologics Effectiveness and Safety (BEST) Initiative - Data Tools and Infrastructure for Surveillance of Biologics indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The contract calls for IBM to provide data, tools, and infrastructure to support HHS FDA's BEST Initiative for surveillance of...